Aurobindo Pharma’s Cronus rethink is positive, but it needs to do more

Aurobindo Pharma terminated an agreement to acquire a majority stake in Cronus Pharma after the proposal stoked capital allocation concerns

from Moneycontrol Business News https://www.moneycontrol.com/news/business/aurobindo-pharma’s-cronus-rethink-is-positiveit-needs-to-do-more_15472941.html